1. Home
  2. LAW vs ESPR Comparison

LAW vs ESPR Comparison

Compare LAW & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAW
  • ESPR
  • Stock Information
  • Founded
  • LAW 2013
  • ESPR 2008
  • Country
  • LAW United States
  • ESPR United States
  • Employees
  • LAW N/A
  • ESPR N/A
  • Industry
  • LAW Computer Software: Prepackaged Software
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAW Technology
  • ESPR Health Care
  • Exchange
  • LAW Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • LAW 306.1M
  • ESPR 305.0M
  • IPO Year
  • LAW 2021
  • ESPR 2013
  • Fundamental
  • Price
  • LAW $4.46
  • ESPR $1.61
  • Analyst Decision
  • LAW Hold
  • ESPR Buy
  • Analyst Count
  • LAW 4
  • ESPR 7
  • Target Price
  • LAW $6.88
  • ESPR $6.36
  • AVG Volume (30 Days)
  • LAW 139.2K
  • ESPR 4.2M
  • Earning Date
  • LAW 05-08-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • LAW N/A
  • ESPR N/A
  • EPS Growth
  • LAW N/A
  • ESPR N/A
  • EPS
  • LAW N/A
  • ESPR N/A
  • Revenue
  • LAW $144,841,000.00
  • ESPR $332,314,000.00
  • Revenue This Year
  • LAW $5.43
  • ESPR $5.51
  • Revenue Next Year
  • LAW $5.64
  • ESPR $1.42
  • P/E Ratio
  • LAW N/A
  • ESPR N/A
  • Revenue Growth
  • LAW 4.89
  • ESPR 185.66
  • 52 Week Low
  • LAW $4.19
  • ESPR $1.47
  • 52 Week High
  • LAW $8.57
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • LAW 40.90
  • ESPR 48.04
  • Support Level
  • LAW $4.20
  • ESPR $1.47
  • Resistance Level
  • LAW $4.67
  • ESPR $1.61
  • Average True Range (ATR)
  • LAW 0.19
  • ESPR 0.13
  • MACD
  • LAW 0.00
  • ESPR 0.01
  • Stochastic Oscillator
  • LAW 36.97
  • ESPR 51.28

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: